New Vaccines for the Prevention of Pneumococcal Infections

Streptococcus pneumoniae is a major cause of acute otitis media, pneumonia, bacteremia, and meningitis. Because in recent years antibiotic-resistant pneumococcal strains have been emerging throughout the world, vaccination against pneumococcal infections has become more urgent. The capsular polysacc...

Full description

Bibliographic Details
Main Authors: Helena Käyhty, Juhani Eskola
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 1996-10-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/2/4/96-0404_article
_version_ 1831739035876327424
author Helena Käyhty
Juhani Eskola
author_facet Helena Käyhty
Juhani Eskola
author_sort Helena Käyhty
collection DOAJ
description Streptococcus pneumoniae is a major cause of acute otitis media, pneumonia, bacteremia, and meningitis. Because in recent years antibiotic-resistant pneumococcal strains have been emerging throughout the world, vaccination against pneumococcal infections has become more urgent. The capsular polysaccharide vaccine that has been available is neither immunogenic nor protective in young children and other immunocompromised patients. Several pneumococcal proteins have been proposed as candidate vaccines, but no human studies associated with them have been reported. Clinical trials of first-generation pneumococcal conjugate vaccines have shown that covalent coupling of pneumococcal capsular polysaccharides to protein carriers improves the immunogenicity of the polysaccharides. The protective efficacy of the conjugate vaccines against carriage, acute otitis media, and invasive infections is being studied.
first_indexed 2024-12-21T13:31:45Z
format Article
id doaj.art-232be6d1f37447c1833d1e78d1ed2bf9
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-21T13:31:45Z
publishDate 1996-10-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-232be6d1f37447c1833d1e78d1ed2bf92022-12-21T19:02:16ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60591996-10-012428929810.3201/eid0204.960404New Vaccines for the Prevention of Pneumococcal InfectionsHelena KäyhtyJuhani EskolaStreptococcus pneumoniae is a major cause of acute otitis media, pneumonia, bacteremia, and meningitis. Because in recent years antibiotic-resistant pneumococcal strains have been emerging throughout the world, vaccination against pneumococcal infections has become more urgent. The capsular polysaccharide vaccine that has been available is neither immunogenic nor protective in young children and other immunocompromised patients. Several pneumococcal proteins have been proposed as candidate vaccines, but no human studies associated with them have been reported. Clinical trials of first-generation pneumococcal conjugate vaccines have shown that covalent coupling of pneumococcal capsular polysaccharides to protein carriers improves the immunogenicity of the polysaccharides. The protective efficacy of the conjugate vaccines against carriage, acute otitis media, and invasive infections is being studied.https://wwwnc.cdc.gov/eid/article/2/4/96-0404_articleFinland
spellingShingle Helena Käyhty
Juhani Eskola
New Vaccines for the Prevention of Pneumococcal Infections
Emerging Infectious Diseases
Finland
title New Vaccines for the Prevention of Pneumococcal Infections
title_full New Vaccines for the Prevention of Pneumococcal Infections
title_fullStr New Vaccines for the Prevention of Pneumococcal Infections
title_full_unstemmed New Vaccines for the Prevention of Pneumococcal Infections
title_short New Vaccines for the Prevention of Pneumococcal Infections
title_sort new vaccines for the prevention of pneumococcal infections
topic Finland
url https://wwwnc.cdc.gov/eid/article/2/4/96-0404_article
work_keys_str_mv AT helenakayhty newvaccinesforthepreventionofpneumococcalinfections
AT juhanieskola newvaccinesforthepreventionofpneumococcalinfections